
Dx Deals: QuidelOrtho Acquires LEX Diagnostics, Plans to Switch Out Respiratory Testing Platforms
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2

The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2

Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health

Recent inroads into testing of water for dialysis equipment illustrates Quest’s expanded scope with deals

Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block

The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow